Abstract
Obesity is associated with incident heart failure (HF), independent of other cardiovascular risk factors. Despite rising rates of both obesity and incident HF, the associations remain poorly understood between: 1) obesity and HF outcomes; and 2) weight loss and HF outcomes. Evidence shows that patients with HF and obesity have high symptom burdens, lower exercise capacity, and higher rates of hospitalization for HF when compared with patients with HF without obesity. However, the impact of weight loss on these outcomes for patients with HF and obesity remains unclear. Recent advances in medical therapies for weight loss have offered a new opportunity for significant and sustained weight loss. Ongoing and recently concluded cardiovascular outcomes trials will offer new insights into the role of weight loss through these therapies in preventing HF and mitigating HF outcomes and symptom burdens among patients with established HF, particularly HF with preserved ejection fraction.
Original language | English (US) |
---|---|
Pages (from-to) | 28-34 |
Number of pages | 7 |
Journal | JACC: Heart Failure |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2024 |
Keywords
- clinical trial
- heart failure
- obesity
- weight loss
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine